» Articles » PMID: 35782016

Perampanel Reduces Brain Damage Via Induction of M2 Microglia in a Neonatal Rat Stroke Model

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2022 Jul 5
PMID 35782016
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Ischemic stroke is a leading cause of death and disability worldwide. Additionally, neonatal ischemia is a common cause of neonatal brain injury, resulting in cerebral palsy with subsequent learning disabilities and epilepsy. However, there is currently a lack of effective treatments available for patients with perinatal ischemic stroke. In this study, we investigated the effect of perampanel (PER)-loaded poly lactic-co-glycolic acid (PLGA) by targeting microglia in perinatal stroke.

Methods: After formation of focal ischemic stroke by photothrombosis in P7 rats, PER-loaded PLGA was injected intrathecally. Proinflammatory markers (TNF-α, IL-1β, IL-6, COX2, and iNOS) and M2 polarization markers (Ym1 and Arg1) were evaluated. We investigated whether PER increased M2 microglial polarization in vitro.

Results: PER-loaded PLGA nanoparticles decreased the pro-inflammatory cytokines compared to the control group. Furthermore, they increased M2 polarization.

Conclusion: PER-loaded PLGA nanoparticles decreased the size of the infarct and increased motor function in a perinatal ischemic stroke rat model. Pro-inflammatory cytokines were also reduced compared to the control group. Finally, this development of a drug delivery system targeting microglia confirms the potential to develop new therapeutic agents for perinatal ischemic stroke.

Citing Articles

The inflammasome-activating poxvirus peptide IAMP29 promotes antimicrobial and anticancer responses.

Roh T, Seo W, Won M, Yang W, Sapkota A, Park E Exp Mol Med. 2024; 56(11):2475-2490.

PMID: 39511430 PMC: 11612179. DOI: 10.1038/s12276-024-01339-3.


Rejuvenating aged microglia by p16-siRNA-loaded nanoparticles increases amyloid-β clearance in animal models of Alzheimer's disease.

Shin H, Kim I, Choi S, Lee K, Park H, Shin J Mol Neurodegener. 2024; 19(1):25.

PMID: 38493185 PMC: 10943801. DOI: 10.1186/s13024-024-00715-x.


Nanomaterial payload delivery to central nervous system glia for neural protection and repair.

Saksena J, Hamilton A, Gilbert R, Zuidema J Front Cell Neurosci. 2023; 17:1266019.

PMID: 37941607 PMC: 10628439. DOI: 10.3389/fncel.2023.1266019.


The Recent Applications of PLGA-Based Nanostructures for Ischemic Stroke.

Yan J, Huang L, Feng J, Yang X Pharmaceutics. 2023; 15(9).

PMID: 37765291 PMC: 10535132. DOI: 10.3390/pharmaceutics15092322.


Perioperative perampanel administration for early seizure prophylaxis in brain tumor patients.

Kusakabe K, Inoue A, Watanabe H, Nakamura Y, Nishikawa M, Ohtsuka Y Surg Neurol Int. 2023; 14:287.

PMID: 37680915 PMC: 10481804. DOI: 10.25259/SNI_495_2023.


References
1.
Shin N, Shin H, Yi Y, Beom J, Lee W, Lee C . p66shc siRNA-Encapsulated PLGA Nanoparticles Ameliorate Neuropathic Pain Following Spinal Nerve Ligation. Polymers (Basel). 2020; 12(5). PMC: 7284875. DOI: 10.3390/polym12051014. View

2.
Murabe Y, Sano Y . Morphological studies on neuroglia. V. Microglial cells in the cerebral cortex of the rat, with special reference to their possible involvement in synaptic function. Cell Tissue Res. 1982; 223(3):493-506. DOI: 10.1007/BF00218471. View

3.
Niu H, Wang J, Wang D, Miao J, Li H, Liu Z . The Orally Active Noncompetitive AMPAR Antagonist Perampanel Attenuates Focal Cerebral Ischemia Injury in Rats. Cell Mol Neurobiol. 2017; 38(2):459-466. PMC: 11481974. DOI: 10.1007/s10571-017-0489-x. View

4.
Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F . Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol. 1990; 27(2-3):229-37. DOI: 10.1016/0165-5728(90)90073-v. View

5.
Kim S, Shin J, Tran Q, Park H, Kwon H, Shin N . Application of PLGA nanoparticles to enhance the action of duloxetine on microglia in neuropathic pain. Biomater Sci. 2021; 9(18):6295-6307. DOI: 10.1039/d1bm00486g. View